RecruitingNot ApplicableNCT05866835

Validation of a Digitalised Intraoral Protection

Validation of a Generic Procedure for the Fabrication of a Custom-made Intra-oral Protection Using an Inter-arch Piece


Sponsor

University Hospital, Bordeaux

Enrollment

60 participants

Start Date

Oct 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Type III (custom-made) intra-oral protection (IOP) models represent 13% of IOP worn by amateur rugby club players in France. However, this model is recognized as the most effective when made in accordance with essential health and safety requirements. This observation is at the origin of a new approach that the investigators are proposing with the objective of removing the barriers to access to custom-made IOP. This research is based on the combination of new digital technologies, scanning and 3D printing, to develop a new generation of IOP. This project aims to show the interest of this new generation of "modified unimaxillary" IOP on the ventilation of the athletes and his/her comfort when he/she evolves with his IOP in place


Eligibility

Min Age: 16 YearsMax Age: 35 Years

Inclusion Criteria5

  • Subjects between the ages of 16 and 35,
  • Subject affiliated to a social security system,
  • Subject affiliated with the French Federation of Boxing or Rugby or Football
  • Subject having signed a consent form
  • For minors, legal guardians having signed the free and informed consent form

Exclusion Criteria8

  • Subject with a pathology incompatible with the realization of the trial:
  • Absolute contraindications: Recent infarction (wait 5 to 12 days depending on severity), Threat syndrome (lawful test after stabilization - at least 3 days without spontaneous seizures), Resting BP \> 200/120 mmHg, Uncompensated heart failure, Third-degree Atrioventricular block, Myocarditis, Pericarditis, Endocarditis, Aortic Dissection, Intracardiac tumor or thrombus, Deep venous thrombosis, Pulmonary Embolism,
  • Relative contraindications: Aortic stenosis (formal contraindication if lipothymia, syncope or signs of heart failure), Severe non-revascularized coronary artery disease, Pulmonary arterial hypertension (formal contraindication if primary), Severe rapid ventricular or supraventricular arrhythmias
  • Subject under B-mimetic drug treatment,
  • Subject with decaying teeth,
  • Subject under court protection,
  • Subject participating in another research study,
  • Subject in pregnancy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERManufacture of custom-made IOP

Manufacture of custom-made "unimaxillary" and "modified unimaxillary" intra-oral protection (IOP) with vertical dimensions of 4 mm and 6 mm. 3D modeling of a IOP based on: * digital recording of the maxillary and mandibular dental arches * mandibular wedging performed with an inter-arch piece * digital recording of the inter-arch position

OTHERVentilation tests

Realization of a ventilation test (VO2max) to determine the Maximum Aerobic Speed (MAS). Measurement of ventilatory parameters without IOP and with each IOP : * At rest, standing still. * During a 4 minute run on a treadmill at 50% of MAS. * During a 4-minute run on a treadmill, at a speed corresponding to 70% of MAS

OTHEREvaluation of comfort level:

Collection from participants (self-questionnaire)


Locations(3)

CHU de Bordeaux

Bordeaux, France

CREPS de Bordeaux

Bordeaux, France

Institut national du sport, de l'expertise et de la performance (INSEP)

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05866835